Harvestiro
Founded 2020 · 167 employees on LinkedIn · 1 known investors
Find your way into Harvestiro
Sign up to see every warm intro you have to Harvestiro
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Harvestiro team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HiRO is a full-service global contract research organization (CRO) that manages clinical trials for biotech companies, integrating regulatory strategy, clinical data science, clinical operations, medical monitoring, and quality into a single execution model. It operates across regions including North America and APAC and serves biotech sponsors developing drugs and therapies across therapeutic areas such as oncology and rare diseases.
Founders & leadership
CC

Crista CaseyChief Operations OfficerCrista Casey is a clinical development and operations executive with over 20 years leading large teams through Phase I–III clinical trials across oncology, immunology, infectious disease, and rare disease. She has held COO and EVP-level roles overseeing global operations, clinical delivery, regulatory, data sciences, and quality functions at contract research organizations.
VZ
Valentina Zhukova-HarrillConsulting Medical Monitor
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Harvestiro do?
- HiRO is a full-service global contract research organization (CRO) that manages clinical trials for biotech companies, integrating regulatory strategy, clinical data science, clinical operations, medical monitoring, and quality into a single execution model. It operates across regions including North America and APAC and serves biotech sponsors developing drugs and therapies across therapeutic areas such as oncology and rare diseases.
- Who are Harvestiro's investors?
- Harvestiro's investors include OrbiMed.

